These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37443106)

  • 1. BMP4 upregulates glycogen synthesis through the SMAD/SLC2A1 (GLUT1) signaling axis in hepatocellular carcinoma (HCC) cells.
    Zhong J; Tian L; Gou Y; Zhao P; Dong X; Guo M; Zhao G; Li A; Hao A; He TC; Fan J
    Cancer Metab; 2023 Jul; 11(1):9. PubMed ID: 37443106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway.
    Shang R; Wang M; Dai B; Du J; Wang J; Liu Z; Qu S; Yang X; Liu J; Xia C; Wang L; Wang D; Li Y
    Mol Oncol; 2020 Jun; 14(6):1381-1396. PubMed ID: 32174012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoginkgetin, a potential CDK6 inhibitor, suppresses
    Yao J; Tang S; Shi C; Lin Y; Ge L; Chen Q; Ou B; Liu D; Miao Y; Xie Q; Tang X; Fei J; Yang G; Tian J; Zeng X
    Autophagy; 2023 Apr; 19(4):1221-1238. PubMed ID: 36048765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMP4 augments the survival of hepatocellular carcinoma (HCC) cells under hypoxia and hypoglycemia conditions by promoting the glycolysis pathway.
    Zhong J; Kang Q; Cao Y; He B; Zhao P; Gou Y; Luo Y; He TC; Fan J
    Am J Cancer Res; 2021; 11(3):793-811. PubMed ID: 33791154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA SLC2A1-AS1 induced by GLI3 promotes aerobic glycolysis and progression in esophageal squamous cell carcinoma by sponging miR-378a-3p to enhance Glut1 expression.
    Liu H; Zhang Q; Song Y; Hao Y; Cui Y; Zhang X; Zhang X; Qin Y; Zhu G; Wang F; Dang J; Ma S; Zhang Y; Guo W; Li S; Guan F; Fan T
    J Exp Clin Cancer Res; 2021 Sep; 40(1):287. PubMed ID: 34517880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
    J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
    Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
    Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP4 promotes hepatocellular carcinoma proliferation by autophagy activation through JNK1-mediated Bcl-2 phosphorylation.
    Deng G; Zeng S; Qu Y; Luo Q; Guo C; Yin L; Han Y; Li Y; Cai C; Fu Y; Shen H
    J Exp Clin Cancer Res; 2018 Jul; 37(1):156. PubMed ID: 30012194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMP4 enhances hepatocellular carcinoma proliferation by promoting cell cycle progression via ID2/CDKN1B signaling.
    Ma J; Zeng S; Zhang Y; Deng G; Qu Y; Guo C; Yin L; Han Y; Shen H
    Mol Carcinog; 2017 Oct; 56(10):2279-2289. PubMed ID: 28543546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BTF3 promotes proliferation and glycolysis in hepatocellular carcinoma by regulating GLUT1.
    Wang P; Sun J; Sun C; Zhao H; Zhang Y; Chen J
    Cancer Biol Ther; 2023 Dec; 24(1):2225884. PubMed ID: 37382415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
    Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
    Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP activated Smad signaling strongly promotes migration and invasion of hepatocellular carcinoma cells.
    Maegdefrau U; Bosserhoff AK
    Exp Mol Pathol; 2012 Feb; 92(1):74-81. PubMed ID: 22024355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 14. Solute carrier family 2 members 1 and 2 as prognostic biomarkers in hepatocellular carcinoma associated with immune infiltration.
    Peng Q; Hao LY; Guo YL; Zhang ZQ; Ji JM; Xue Y; Liu YW; Lu JL; Li CG; Shi XL
    World J Clin Cases; 2022 May; 10(13):3989-4019. PubMed ID: 35665115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma.
    Mano Y; Yoshio S; Shoji H; Tomonari S; Aoki Y; Aoyanagi N; Okamoto T; Matsuura Y; Osawa Y; Kimura K; Yugawa K; Wang H; Oda Y; Yoshizumi T; Maehara Y; Kanto T
    J Gastroenterol; 2019 Nov; 54(11):1007-1018. PubMed ID: 30941514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma.
    Ma J; Zeng S; Zhang Y; Deng G; Qu Y; Guo C; Yin L; Han Y; Cai C; Li Y; Wang G; Bonkovsky HL; Shen H
    Cancer Lett; 2017 Dec; 411():117-129. PubMed ID: 28987388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Function of BMP4 in the Formation of Vasculogenic Mimicry in Hepatocellular Carcinoma.
    Li X; Sun B; Zhao X; An J; Zhang Y; Gu Q; Zhao N; Wang Y; Liu F
    J Cancer; 2020; 11(9):2560-2571. PubMed ID: 32201526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-dependent expression of MAP17 coordinates the Warburg effect to tumor growth in hepatocellular carcinoma.
    Dong F; Li R; Wang J; Zhang Y; Yao J; Jiang SH; Hu X; Feng M; Bao Z
    J Exp Clin Cancer Res; 2021 Apr; 40(1):121. PubMed ID: 33832535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis.
    Liu L; Wang Q; Wu L; Zhang L; Huang Y; Yang H; Guo L; Fang Z; Wang X
    Cancer Cell Int; 2023 Jul; 23(1):138. PubMed ID: 37452331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six2 is negatively correlated with prognosis and facilitates epithelial-mesenchymal transition via TGF-β/Smad signal pathway in hepatocellular carcinoma.
    Wan ZH; Ma YH; Jiang TY; Lin YK; Shi YY; Tan YX; Dong LW; Wang HY
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):525-531. PubMed ID: 31564506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.